Madrigal Pharmaceuticals (MDGL)
$293.6 7.6%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
9 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Madrigal Pharmaceuticals, AI stock picks, stock alerts and much more.
MDGL AI Stock Analysis
AI stock analysis for MDGL is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Madrigal Pharmaceuticals (MDGL) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
MDGL Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Madrigal Pharmaceuticals (MDGL), currently trading at $293.6, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About MDGL
-
Madrigal Pharmaceuticals, Inc.
-
Symbol
MDGL
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
6.4B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.78 0.5% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.08 8.9% |
4 |
 |
Moderna MRNA |
$34.06 0.9% |
4 |
 |
Anavex Life Sciences AVXL |
$9.21 9.3% |
6 |
 |
BridgeBio Pharma BBIO |
$33.79 0.9% |
7 |
News
MDGL Alternative Data
News Mentions
Sign up to access
Twitter Followers
Sign up to access
Facebook Engagement
Sign up to access
Youtube Subscribers
Sign up to access
LinkedIn Followers
Sign up to access
Job Postings
Sign up to access
LinkedIn Employees
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
MDGL Financials
MDGL Key Metrics
-
Total Revenue
$62.2M
-
Net Income
-$107M
-
Earnings per Share
-$4.92
-
Free cash flow
-$62.8M
-
EBITDA
-$116.3M
-
EBITDA Ratio
-1.87059
-
Total Assets
$1.1B
MDGL 2-year Revenue & Income
MDGL 2-year Free Cash Flow
MDGL Technicals
MDGL SMA
MDGL RSI
FAQ
What's the current price of Madrigal Pharmaceuticals (MDGL) Stock?
The price of an Madrigal Pharmaceuticals (MDGL) share is $293.6.
What's the market cap of Madrigal Pharmaceuticals?
The current market cap of Madrigal Pharmaceuticals is 6.4B.
Should I buy or sell MDGL?
Madrigal Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Madrigal Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.
Is Madrigal Pharmaceuticals a good investment?
The current analysis of Madrigal Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Madrigal Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Madrigal Pharmaceuticals (MDGL) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Madrigal Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Madrigal Pharmaceuticals (MDGL) that investors often compare it to?
Madrigal Pharmaceuticals (MDGL) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Madrigal Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Madrigal Pharmaceuticals' stock price to be around $307.4 in 2026. Starting from the current price of $293.6, this represents a 4.7% change in price, indicating a neutral outlook for the stock.
How to buy Madrigal Pharmaceuticals (MDGL) Stock?
Madrigal Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Madrigal Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.